|Articles|October 7, 2021

Though HIV Deaths are Decreasing, Women and Black Women Still Have Significantly Higher Mortality Rates

Author(s)Nina Cosdon

A recent study measured premature deaths among people with HIV by sex, race, and HIV risk factor.

HIV-related mortalities have decreased with the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), but this may fail to account for premature deaths among people with HIV, according to a study presented virtually at IDWeek.

Investigators assessed trends in all-cause and premature mortality by sex, race, and HIV risk factor among people with HIV (PWH). They used data from patients receiving care at the Vanderbilt Comprehensive Care Clinic from January 1998-December 2018, examining mortality trends using person-time from clinic admittance to date of death or December 31, 2018. They compared mortality rates by demographic and clinical factors, calculating adjusted incidence rate ratios (aIRR) and 95% confidence intervals (CI) by using multivariable Poisson regression.

For study subjects who died, investigators obtained years of potential life lost (YPLL) from estimated US sex-specific period life tables of age and year of death. They analyzed patient risk factors associated with YPLL using multivariable linear regression.

The study included 6531 patients in the Vanderbilt Comprehensive Care Clinic system, 959 (14.6%) of whom died. During the almost 20-year study period, mortality rates decreased drastically. The investigators adjusted the results for adjusting for calendar era, age, injection drug use, hepatitis C virus (HCV), year of HIV diagnosis, history of AIDS-defining illness, CD4 cell count, and HIV RNA at clinic entry. After these adjustments, they found that female sex was correlated with increased mortality risk. Higher YPLL remained associated with non-Hispanic Black race and female sex regardless of HIV risk factor and younger age at HIV diagnosis.

Though there has been significant improvement in reducing HIV mortality rate over time, sex disparities in mortality and sex and race disparities in YPLL remained prevalent in PWH clinic patients. The investigators noted, “YPLL is a useful measure for examining persistent gaps in longevity and premature mortality among PWH.”


Related to this article

FDA Approves Tivicay PD for Infants With HIV
The federal agency gave the nod to dolutegravir (Tivicay PD), making it the first second-generation integrase inhibitor cleared for children with HIV weighing at least 2 kg, including eligible newborns.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.